5556
O. Artyushin et al. / Journal of Organometallic Chemistry 691 (2006) 5547–5559
of diethyl ether under argon and the mixture was stirred for
additional 5 min. Then the solution of 2 mmol of the corre-
sponding alcohol in 30 mL of diethyl ether was added. The
mixture was allowed to warm up to ambient temperature
and stirred for additional 3 h. The precipitate was filtered
off under argon, washed with Et2O (2 · 30 mL) and dis-
carded. The filtrate was evaporated in vacuo. The residue
was treated with 30 mL of pentane and kept at 0 ꢁC over-
night. The clear solution was decanted from the precipitate
and evaporated under reduced pressure followed by drying
(20 ꢁC, 0.1 mmHg, 2 h) to afford the desired amidophosph-
ites (8a–c, 9a–c) as a colourless oils.
(m, 2H, NCH2); 4.10–4.54 (m, OCH2, 2H); 5.35–5.50 (m,
1H, OCH). 13C NMR: 22.2 (br., CH3); 30.9 (d, CH3N,
2
2JP–C = 15.3 Hz), 31.1 (d, CH3N, JP–C = 15.4 Hz); 48.8
2
2
(d, CH2N, JP–C = 5.1 Hz), 48.9 (d, CH2N, JP–C = 5.1
2
Hz); 66.4 (d, OCH, JP–C = 5.8 Hz), 66.7 (d, OCH,
2JP–C = 5.8 Hz); 68.7 (d, OCH2, JP–C = 5.8 Hz), 130.6
2
(br), 135.8 (br.m), 136.0 (br.m), 138.5 (br.m), 143.1
(br.m), 145.7 (br.m). Anal. Calc. for C11H11F5NO2P:
C, 41.92; H, 3.52; N, 4.44. Found: C, 41.48; H, 3.65; N,
4.42%.
3.2.15. 1,3-Dimethyl-2-(2,2,2-trifluoro-1-phenylethoxy)-
1,3,2-diazaphospholidine 9a
3.2.12. 3-Methyl-2-{2,2,2-trifluoro-1-[3-
(trifluoromethyl)phenyl]ethoxy}-1,3,2-oxazaphospholidine
8a
Yield 88%. 31P NMR: 132.4 (br.s); 19F NMR: ꢀ77.11
3
4
1
(dd, JF–H = 7.0 Hz, JP–F = 4.1 Hz); H NMR: 2.46 and
3
2.57 (both d, 6H, CH3N, JP–H = 12.2 Hz); 3.00–3.35 (m,
Yield 90%. 31P NMR: 142.1 (A), 143.7 (B) (both br.s,
A:B = 1:1.3); 19F NMR: ꢀ63.5 (br.s, CF3Ar), ꢀ77,9 and
4H, CH2N); 5.12 (appeared quintet, 1H, CH, JP–H
=
3
3JP–H = 7.0 Hz,); 7.35–7.51 (m, 5H, Ph). 13C NMR: 33.0
1
2
2
ꢀ78,2 (both br.s, CF3CH, A and B); H NMR: 2.72 and
(d, CH3N, JP–C = 22.6 Hz), 33.4 (d, CH3N, JP–C =
24.8 Hz); 52.1 (d, CH2N, JP–C = 10.9 Hz), 52.5 (d,
3
2
2.64 (d, 3H, CH3N, JP–H = 12 Hz); 2.95–3.30 (m, 2H,
2
2
CH2N); 5.18–5.35 (m, 1H, CH); 3.45–4.12 (m, 2H,
CH2N, JP–C = 10.2 Hz); 72.1 (qd, CH, JC–F = 31.3 Hz,
2
1
CH2O). 13C NMR: 30.5 (d, CH3N, JP–C = 20.4 Hz), 30.6
2JP–C = 7.3 Hz); 124.1 (qd, CHCF3, JC–F = 280.1 Hz,
2
2
(d, CH3N, JP–C = 21.9 Hz); 48.4 (d, CH2N, JP–C
=
3JP–C = 3.6 Hz);127.6 (o-CAr), 128.0 (m-CAr), 128.7 (p-
CAr), 134.7 (ipso-CAr). EI-MS, m/z 293 (M+H)+.
2
5.8 Hz), 48.7 (d, CH2N, JP–C = 5.1 Hz); 69.0 (d, CH2O,
2JP–C = 9.5 Hz), 69.1 (d, CH2O, JP–C = 10.2 Hz); 71.7
2
2
2
(dq, CH, JC–F = 32.8 Hz, JP–C = 13.1 Hz), 72.1 (dq,
2
2
3.2.16. Diethyl 1-[(1,3-dimethyl-1,3,2-diazaphospholidin-2-
yl)oxy]-2,2,2-trifluoroethylphosphonate 9b
CH, JC–F = 32.8 Hz, JP–C = 15.3); 123.5 (dq, CHCF3,
1JC–F = 283.1 Hz, JP–C = 7.3 Hz); 124.3 (m); 124.8 (q,
3
Yield 96%. 31P NMR: 14.3 (m, PIV), 144.9 (br.s, PIII);
1
Ar-CF3, JC–F = 269.2 Hz); 125.9 (m); 128.75; 128.83;
130.6 (d, OCH–CAr, JP–C = 7.3 Hz); 130.9 (br); 135.2;
3
4
19F NMR: ꢀ72.11 (dd, JF–H = 8.0 Hz, JP–F = 7.5 Hz);
3
1H NMR: 1.35 (t, 6H, CH3C, JH–H = 6.1 Hz); 2.71 and
3
135.3. Anal. Calc. for C12H12F6NO2P: C, 41.51; H, 3.48;
N, 4.03. Found: C, 41.04; H, 3.53; N, 3.90%.
3
2.77 (both d, 6H, CH3N, JP–H = 12.1 Hz); 3.05–3.35 (m,
4H, CH2N); 4.11–4.40 (m, 4H, CH2O), 4.53 (dq, 1H,
3
2
CH, JF–H = 8.0 Hz, JP–H = 20.1 Hz). 13C NMR: 16.0
3
2
3.2.13. Diethyl 2,2,2-trifluoro-1-[(3-methyl-1,3,2-
oxazaphospholidin-2-yl)oxy]ethylphosphonate 8b
Yield 85%. 31P NMR: 13.5 (m, PIV), 147.2 (br.s, PIII);
(d, CH3CH2OP, JP–C = 5.3 Hz), 33.5 (d, CH3N, JP–C =
22.8 Hz), 33.8 (d, CH3N, JP–C = 24.3 Hz); 52.2 (d,
CH2N, JP–C = 9.9 Hz), 52.3 (d, CH2N, JP–C = 9.9 Hz);
2
2
2
1
2
19F NMR: ꢀ72.07 and ꢀ72.45 (both m); H NMR: 1.37
63.1 (d, P(O)OCH2, JP–C = 6.8 Hz), 63.2 (d, P(O)OCH2,
3
2
(t, 6H, CH3C, JH–H = 6 Hz), 2.76 and 2.80 (both d, 3H,
2JP–C = 6.9 Hz); 68.2 (dqd, OCH, JD(III)-C = 13.7 Hz,
3
1
NCH3, JP–H = 12 Hz); 3.00–3.25 (m, 2H, NCH2); 4.45–
2JC–F = 32.7 Hz, JP(IV)-C = 170.3 Hz); 122.9 (qd, CHCF3,
4.65 (m, CH, 1H); 4.10–4.50 (m, OCH2, 6H). 13C NMR:
1JC–F = 281.1 Hz, 3JP–C = 8.1 Hz). Anal. Calc. for
C10H21F3N2O4P2: C, 34.10; H, 6.01; P, 17.59. Found: C,
33.98; H, 6.00; P, 16.99%.
15.6 (d, CH3CH2OP, 3JP–C = 5.5 Hz), 15.7 (d, CH3CH2OP,
2
3JP–C = 5.5 Hz); 30.2 (d, CH3N, JP–C = 19.7 Hz), 30.6 (d,
2
2
CH3N, JP–C = 20.4 Hz); 47.8 (d, CH2N, JP–C = 5.8 Hz),
2
48.2 (d, CH2N, JP–C = 5.8 Hz); 62.9, 63.0, 63.2, 63.4 (all
2
3.2.17. 1,3-Dimethyl-2-{[1-(trifluoromethyl)heptyl]oxy}-
1,3,2-diazaphospholidine 9c
d, CH3CH2OP, JP–C = 6.6 Hz); 66.6 and 68.2 (both m,
OCH); 68.5, 68.7 (both d, PIIIOCH2, JP–C = 10.2 Hz),
2
Yield 98%. 31P NMR: 141.3 (br.s); 19F NMR: ꢀ78.2
1
122.3 (q of m, CHCF3, JC–F = 282.0 Hz). EI-MS, m/z
3
(appeared t, JF–H = 4JP–F = 7.5 Hz); 1H NMR: 0.90 (t,
340 (M+H)+.
3
3H,CH3C, JH–H = 6.2 Hz); 1.15–1.25 (m, 8H, –(CH2)4–);
1.60–1.75 (m, 2H, OCH2); 2.71 and 2.75 (d, 6H, CH3N,
3JP–H = 14.2 Hz); 3.00–3.15 and 3.25–3.35 (m, 4H,
CH2N); 4.00–4.25 (m, 1H, CH). 13C NMR: 13.7 (CH3);
22.3, 24.6, 28.7, 29.8, 31.5 ((CH2)5); 33.7 (d, CH3N,
3.2.14. 3-Methyl-2-[1-(pentafluorophenyl)ethoxy]-1,3,2-
oxazaphospholidine 8c
Yield 82%. 31P NMR: 141.0 and 140.7 (overlapping m);
19F NMR: 143.4 (m, o-FAr), 156.2 (m, p-FAr), 162.8 (m, m-
2
2JP–C = 21.9 Hz), 34.2 (d, CH3N, JP–C = 24.8 Hz); 52.4
1
3
2
2
FAr); H NMR: 1.61 (d, 3H, CH3CH, JH–H = 6 Hz); 2.63
(d, CH2N, JP–C = 9.5 Hz), 52.5 (d, CH2N, JP–C = 9.5
3
2
2
and 2.70 (both d, 3 H, NCH3, JP–H = 10 Hz); 2.90–3.24
Hz); 71.1 (qd, CH, JC–F = 29.9 Hz, JP–C = 17.5 Hz);